Table 1 Groups’ characteristics
From: A quest for sphincter-saving surgery in ultralow rectal tumours—a single-centre cohort study
APR | Intersphincteric | TaTME | p value | |
|---|---|---|---|---|
Males/females, n (%) | 8/5 (52%/48%) | 12/2 (86%/14%) | 19/6 (76%/24%) | 0.345 |
Median age, years (IQR) | 60 (55–71) | 63 (50–69) | 65 (59.5–72.5) | 0.462 |
Median BMI, kg/m2 (IQR) | 24.91 (22.31–27.40) | 24.82 (24.15–28.73) | 24.80 (21.94–26.47) | 0.715 |
ASA class | ||||
3 | 3 (23.08%) | 6 (42.86%) | 4 (16%) | 0.175 |
2 | 10 (76.92%) | 8 (57.14%) | 21 (84%) | |
T | ||||
3 | 7 (53.85%) | 6 (42.86%) | 15 (60%) | 0.311 |
2 | 4 (30.77%) | 4 (28.57%) | 1 (4%) | |
1 | 1 (7.69%) | 1 (7.14%) | 2 (8%) | |
0 | 1 (7.69%) | 3 (21.43%) | 7 (28%) | |
N | ||||
2 | 0 | 1 (7.14%) | 5 (20%) | 0.381 |
1 | 2 (15.38%) | 3 (21.43%) | 5 (20% | |
0 | 11 (84.62%) | 10 (71.43%) | 15 (60%) | |
M | ||||
1 | 0 | 0 | 3 (12%) | 0.179 |
0 | 13 (100%) | 14 (100%) | 22 (88%) | |
AJCC | ||||
4 | 0 | 0 | 4 (16%) | 0.414 |
3 | 4 (30.77%) | 6 (42.86%) | 6 (24%) | |
2 | 7 (53.85%) | 5 (35.71%) | 7 (28%) | |
1 | 1 (7.69%) | 1 (7.14%) | 4 (16%) | |
0 | 1 (7.69%) | 2 (14.29%) | 4 (16%) | |
Neoadjuvant treatment, n (%) | 11 (84.62%) | 13 (92.86%) | 24 (96%) | 0.456 |
Adjuvant treatment, n (%) | 6 (46%) | 7 (50%) | 13(52%) | 0.943 |
Tumour regression grade (TRG) | ||||
3 | 1 (7.69%) | 2 (14.29%) | 3 (12%) | 0.949 |
2 | 7 (53.85%) | 7 (50%) | 14 (56%) | |
1 | 4 (30.77%) | 3 (21.43%) | 4 (16%) | |
0 | 1 (7.69%) | 2 (14.29%) | 4 (16%) | |